Clinical Trial Update: A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML [Phase 2]

View source ↗

Summary

Phase 2 study evaluating JCPyV-specific T cell therapy for Progressive Multifocal Leukoencephalopathy is in early results with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• JCPyV-specific T cell therapy

Snippet

Sponsor: Cellevolve Bio Inc | Conditions: Progressive Multifocal Leukoencephalopathy | Phase 2 | Status: UNKNOWN